• Login
    View Item 
    •   Repository Home
    • Journal Articles
    • College of Health Sciences (CHS)
    • View Item
    •   Repository Home
    • Journal Articles
    • College of Health Sciences (CHS)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    HER2/Neu Protein Over-Expression in Patients with Gastric and Gastro-Esophageal Junction Carcinoma Seen at Kenyatta National Hospital, Kenya

    Thumbnail
    View/Open
    Full text (2.663Mb)
    Date
    2014
    Author
    Ali, Hussein A
    Rogena, Emily
    Omulo, TM
    Ndaguatha, PLW
    Metadata
    Show full item record
    Abstract
    Background: Gastric cancer in Kenya is ranked third in both males and females. Most patients present clinically with advanced unsusceptible disease have poor prognosis despite administration of standard chemotherapy. Human epidermal growth factor receptor–2 (HER-2) over expression in gastric cancer is related to poor outcome. Advances in molecular therapy, have identified HER-2 to be an important component in the treatment of advanced gastric cancer. The prevalence of HER-2 in Kenya is unknown. Objective: To determine the prevalence of HER-2 overexpression in patients with gastric and gastrooesophageal junction carcinoma at Kenyatta National Hospital. Methodology: Descriptive Cross sectional study on patients with histological diagnosis from endoscopic/ resection specimens of gastric or GEJ cancer at KNH. A sample of 66 patients was selected by progressive sampling. Approval was obtained from the KNH/UON ethics and research committee. Data was collected using a pretested questionnaire. All tissue blocks were tested for HER-2 receptor protein using IHC. Data entry and analysis was done via SPSS version 21.0. Results: Study sample of 66 patients were included in the study with a mean age of 60.7 years and males consisting of 66.7%. 42 specimens were obtained from OGD and 24 from surgically resected specimens. Approximately 91% of the tumours were located in the gastric region. Gastric adenocarcinoma accounted for 89.4% (N=59) mainly intestinal (78.8%, N=52) and diffuse (9.1%, N=6) while 1.5% (N=1) was adeno-squamous. HER-2 over-expression was diagnosed in 42.4% (N=28) of patients. HER-2 over-expression was not significantly associated with age (P=0.844) and gender (P=0.682). The anatomical site was not significantly associated with HER-2 over-expression (P=1). HER-2 over-expression was found mostly in adenocarcinoma (96.4%) compared to 3.6% in adeno-squamous, with intestinal type showing highest rate of over-expression (87.5%) compared to diffuse (12.5%). Conclusion: HER-2 over-expression was found to be higher in our study (42.4%) compared to most of the studies. HER-2 over-expression is observed predominantly in intestinal type of gastric and GEJ adenocarcinomas.
    URI
    http://www.omicsonline.org/open-access/herneu-protein-overexpression-in-patients-with-gastric-and-gastro-esophageal-junction-carcinoma-seen-at-kenyatta-national-hospital-kenya-2157-2518-5-186.php?aid=30877
    http://hdl.handle.net/11295/87444
    Collections
    • College of Health Sciences (CHS) [9466]

    UoN Digital Archive copyright © 2002-2015  Library Department
    Contact Us | Send Feedback
     

     

    Browse

    All of RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    UoN Digital Archive copyright © 2002-2015  Library Department
    Contact Us | Send Feedback